Re: Address your Shareholders Donald J. McCaffrey
|
4
|
Resverlogix Corp.
|
May 13, 2020 03:10PM
|
Re: Inflammation revisited
|
5
|
Resverlogix Corp.
|
May 12, 2020 11:18PM
|
Re: Zacks
|
3
|
Zenith Epigenetics
|
May 07, 2020 01:28PM
|
Re: https://scr.zacks.co...
|
4
|
Zenith Epigenetics
|
May 06, 2020 03:21PM
|
Re: https://scr.zacks.co...
|
4
|
Zenith Epigenetics
|
May 05, 2020 07:32PM
|
SO078 APABETALONE, A BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES ALKALINE PHOSPHATASE IN CVD PATIENTS....
|
3
|
Resverlogix Corp.
|
May 02, 2020 11:35PM
|
From 2018.
|
4
|
Resverlogix Corp.
|
May 02, 2020 11:30PM
|
Re: Is this going to become
|
4
|
Resverlogix Corp.
|
Apr 30, 2020 01:14PM
|
Re: Endpoints article about Pfizer and M&A
|
4
|
Zenith Epigenetics
|
Apr 29, 2020 07:53PM
|
Whatever happened to the update on our trial? Stalled like everything else here.
|
3
|
Resverlogix Corp.
|
Apr 23, 2020 05:24PM
|
Re: BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO.
|
4
|
Resverlogix Corp.
|
Apr 23, 2020 05:03PM
|
Re: BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO.
|
2
|
Resverlogix Corp.
|
Apr 23, 2020 03:54PM
|
BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO.
|
1
|
Resverlogix Corp.
|
Apr 23, 2020 02:16PM
|
Very interesting posts lately!
|
2
|
Zenith Epigenetics
|
Apr 23, 2020 01:00AM
|
Re: RVX 208 and the cytokine storm syndrome
|
3
|
Resverlogix Corp.
|
Apr 20, 2020 12:20PM
|
Re: Random thoughts RVX-208 and COVID-19
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 04:04PM
|
Re: Shawn lu RSU and option cancelled
|
3
|
Resverlogix Corp.
|
Apr 06, 2020 02:27PM
|
Watch it before it gets moved to "Off Topic Forum" by the thought police here.
|
4
|
Zenith Epigenetics
|
Apr 04, 2020 12:29AM
|
Haven't written off a potential role for Apabetalone to play yet.
|
7
|
Resverlogix Corp.
|
Apr 01, 2020 07:18PM
|
Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach.
|
5
|
Zenith Epigenetics
|
Mar 28, 2020 06:13PM
|